251 Results for "

overexpressing

" in MedChemExpress (MCE) Product Catalog:
Products (251)

251 Results for "overexpressing" in MCE Product Catalog:

66
66 Publications Verification
Cat. No.: HY-P9907A
CAS No.: 180288-69-1
Synonyms: Anti-Human HER2, Humanized Antibody (anti-HER2)

Target:  

ADC Antibodies EGFR

Research Areas:  

Cancer

Trastuzumab (anti-HER2) is a humanized IgG1 monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab (anti-HER2) has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research.
loading...
    loading...
55
55 Cited Publications
Cat. No.: HY-100111
CAS No.: 835598-94-2
Purity:  99.48%
Target:  

NADPH Oxidase

Research Areas:  

Metabolic Disease

GLX351322 is an inhibitor of NADPH oxidase 4 (Nox4), and inhibits hydrogen peroxide production from NOX4-overexpressing cells with an IC50 of 5 μM.
loading...
    loading...
33
33 Cited Publications
Cat. No.: HY-136057
CAS No.: 150651-39-1
Purity:  99.96%
Research Areas:  

Cancer

iFSP1 is a potent, selective and glutathione-independent inhibitor of ferroptosis suppressor protein 1 (FSP1) (AIFM2) with an EC50 of 103 nM. iFSP1 selectively induces ferroptosis in GPX4-knockout cells which overexpressed FSP1. iFSP1 is able to sensitize a variety of human cancer cell lines to the ferroptosis inducer, such as (1S,3R)-RSL3 (HY-100218A) .
loading...
    loading...
32
32 Cited Publications
Cat. No.: HY-101966
CAS No.: 1916571-90-8
Purity:  99.69%
NCT-503 is a blood-brain barrier-permeable, non-competitive PHGDH inhibitor with an IC50 of 2.5 μM against human PHGDH. NCT-503 reduces glucose-derived serine production and the incorporation of one-carbon units into nucleotides without decreasing PHGDH protein expression. NCT-503 prevents high selenium-induced insulin resistance in mice by regulating blood glucose and insulin levels and improving glucose tolerance, and also inhibits the growth of tumors overexpressing PHGDH. NCT-503 can be used in research related to insulin resistance and breast cancer .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-136626
CAS No.: 149697-16-5
Purity:  99.43%
Synonyms: Cbz-Ala-Ala-Asn-AMC
Target:  

Fluorescent Dye

Research Areas:  

Cancer

Z-Ala-Ala-Asn-AMC (Cbz-Ala-Ala-Asn-AMC) is the legumain substrate. Overexpressed legumain in 293 HEK-Leg cells potently cleaved CBZ-Ala-Ala-Asn-AMC .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-115831
CAS No.: 1315311-14-8
Purity:  99.38%
Synonyms: S1P1 agonist 3
Target:  

LPL Receptor

Research Areas:  

Cardiovascular Disease

SAR247799 (S1P1 agonist 3) is an oral activity, selective G-protein-biased sphingosine-1 phosphate receptor-1 (S1P1 ) agonist, with EC50s rang from 12.6 to 493 nM in S1P1-overexpressing cells and HUVECs. SAR247799 can be used for the research of endothelial protection, including type-2 diabetes, metabolic syndrome .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-129390
CAS No.: 1655504-04-3
Purity:  99.97%
Synonyms: ICP-022
Target:  

Btk

Research Areas:  

Cancer

Orelabrutinib (ICP-022) is a potent, orally active, and irreversible Bruton's tyrosine kinase (BTK) inhibitor with potential antineoplastic activity. Orelabrutinib prevents both the activation of the B-cell antigen receptor (BCR) signaling pathway and BTK-mediated activation of downstream survival pathways, inhibiting the growth of malignant B-cells that overexpress BTK .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-109050
CAS No.: 1637771-14-2
Purity:  98.04%
Synonyms: GS-5829
Research Areas:  

Cancer

Alobresib (GS-5829) is a BET bromodomain inhibitor, which represents a highly effective therapeutics agent against recurrent/chemotherapy resistant uterine serous carcinoma (USC) overexpressing c-Myc. Alobresib can be used in the metastatic castration-resistant prostate cancer (mCRPC) research .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P2526
CAS No.: 454487-07-1
Target:  

Complement System

Research Areas:  

Cancer

LyP-1 is a cyclic 9-amino-acids tumor homing peptide and selectively bind to p32 receptors overexpressed in various tumor-associated cells .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P2526A
Target:  

Peptides

Research Areas:  

Cancer

LyP-1 TFA is a cyclic 9 amino acids tumor homing peptide and selectively bind to p32 receptors overexpressed in various tumor-associated cells .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-12762
CAS No.: 944328-88-5
Purity:  99.10%
Research Areas:  

Cancer

QS11 is an inhibitor of ARFGAP1 (ADP-ribosylation factor GTPase-activating protein 1), with an EC50 of 1.5 μM. QS11 activates Wnt/β-catenin signaling through an effect on protein trafficking. QS11 inhibits migration of ARFGAP overexpressing breast cancer cells .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-114358
CAS No.: 1646839-59-9
Purity:  98.59%
Synonyms: ONO-7475
Research Areas:  

Cancer

Tamnorzatinib (ONO-7475) is a potent, selective, and orally active Axl/Mer inhibitor with IC50 values of 0.7 nM and 1.0 nM, respectively. Tamnorzatinib sensitizes AXL-overexpressing EGFR-mutant NSCLC cells to the EGFR-TKIs, suppresses the emergence and maintenance of tolerant cells. Tamnorzatinib combines with Osimertinib (HY-15772) provides a bright promise for the study of EGFR-mutated non-small cell lung cancer (NSCLC).
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-10325
CAS No.: 194423-06-8
Purity:  98.05%
Synonyms: EKI-785; WAY-EKI 785
Target:  

EGFR Apoptosis

Research Areas:  

Endocrinology Cancer

CL-387785 (EKI-785; WAY-EKI 785) is an orally active EGFR inhibitor with an IC50 of 370 pM. CL-387785 inhibits EGF-stimulated EGFR autophosphorylation with an IC50 of approximately 5 nM. CL-387,785 exerts selective inhibition on cell lines overexpressing EGFR or c-erbB-2, whereas it shows weak inhibitory effects on cell lines with low expression of these two receptors. CL-387785 effectively induces cell cycle arrest and apoptosis. CL-387785 can be used for the research of non-small cell lung cancer and autosomal recessive polycystic kidney disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-33299
CAS No.: 154235-77-5
Synonyms: BTCA
Research Areas:  

Cancer

Serpin B9-IN-1 (BTCA) is an inhibitor that specifically targets Serpin B9 (SB9); SB9 is a natural inhibitor of granzyme B (GrB) , but may promote the metastasis of lung cancer cells into the bone marrow. SB9-overexpressing cancer cells promote proliferation and metastasis in an immune cell-dependent manner by binding to GrB. Inhibition of SB9 by Serpin B9-IN-1 significantly inhibits immunotherapy of lung cancer bone metastases in the caudal artery (CA) mouse model (LCBM) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-107760
CAS No.: 150113-99-8
Purity:  98.02%
Synonyms: DecRVKRcmk
Target:  

HIV

Research Areas:  

Infection Inflammation/Immunology

Decanoyl-RVKR-CMK (DecRVKRcmk) inhibits over-expressed gp160 processing and HIV-1 replication .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-107760A
CAS No.: 2098497-25-5
Purity:  96.40%
Synonyms: DecRVKRcmk TFA
Target:  

HIV

Research Areas:  

Infection Inflammation/Immunology

Decanoyl-RVKR-CMK (DecRVKRcmk) TFA inhibits over-expressed gp160 processing and HIV-1 replication .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-132934
CAS No.: 2760674-72-2
Purity:  99.50%
Target:  

BCRP

Research Areas:  

Cancer

Ac32Az19 is a potent, nontoxic, and highly selective BCRP inhibitor with an EC50 value of 13 nM in the BCRP-overexpressed HEK293/R2 cells.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-175324
CAS No.: 3098773-64-6
Target:  

Molecular Glues HuR

Research Areas:  

Cancer

MG-HuR2 is a molecular glue degrader targeting the oncogenic RNA-binding protein HuR (IC50=0.5 μM). MG-HuR2 is promising for research of HuR-overexpressing malignancies (e.g., breast cancer) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99700
CAS No.: 2283356-07-8
Synonyms: IBI-188

Target:  

Inhibitory Antibodies

Research Areas:  

Cancer

Letaplimab (IBI-188) is a human IgG4 anti-CD47 monoclonal antibody. CD47 is overexpressed on cancer cells, it is a ligand for SIRPα. Letaplimab enhances tumor cell phagocytosis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-Q51222
CAS No.: 100264-64-0
Research Areas:  

Cancer

ZINC110492 is a selective ligand of CS-ΔEx4 (a splicing isoform of citrate synthase (CS)). ZINC110492 does not bind to CS full-length (CS-FL). ZINC110492 inhibits colorectal cancer (CRC) cell growth in cells overexpressing CS-ΔEx4 with an IC50 of 7.840 µM. ZINC110492 significantly decreases both citrate and 2-hydroxyglutarate (2-HG) levels in the CS-ΔEx4-overexpressing SW1116 cells .
loading...
    loading...